Nichols Weston

CIK 00017463765 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001746376

Recent Transactions

39 trades

Purchase
Cullinan Therapeutics, Inc.$CGEM
Common stock, $0.0001 par value per share
2025-10-28$8.40/sh+165,667→ 8,963,500 total
Purchase
Neuphoria Therapeutics Inc.$NEUP
Common stock, $0.00001 par value per share
2025-10-21$5.14/sh+639,110→ 875,328 total
Purchase
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2025-10-17$7.84/sh+32,217→ 8,797,833 total
Purchase
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2025-10-16$8.86/sh+150,000→ 8,765,616 total
Purchase
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2025-10-15$7.94/sh+51,500→ 8,615,616 total
Purchase
Cullinan Therapeutics, Inc.$CGEM
Common stock, $0.0001 par value per share ("Common Stock")
2025-10-14$7.59/sh+15,032→ 8,564,116 total
Purchase
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2025-10-10$7.36/sh+277,298→ 8,549,084 total
Purchase
Cullinan Therapeutics, Inc.$CGEM
Common Stock
2025-10-09$6.70/sh+626,043→ 8,271,786 total
Purchase
Cullinan Therapeutics, Inc.$CGEM
Common stock, $0.0001 par value per share ("Common Stock")
2025-10-08$6.46/sh+556,300→ 7,645,743 total
Purchase
Passage BIO, Inc.$PASG
Common Stock
2025-09-15$6.99/sh+11,900→ 623,704 total
Purchase
Passage BIO, Inc.$PASG
Common Stock
2025-09-12$6.99/sh+19,783→ 611,804 total
Purchase
Passage BIO, Inc.$PASG
Common stock, $0.0001 par value per share (Common Stock)
2025-09-11$6.96/sh+325→ 592,021 total
Purchase
Passage BIO, Inc.$PASG
Common Stock
2025-07-24$5.71/sh+66,423→ 591,696 total
Purchase
Passage BIO, Inc.$PASG
Common Stock
2025-07-23$5.74/sh+49,302→ 525,273 total
Purchase
Passage BIO, Inc.$PASG
Common stock, $0.0001 par value per share ("Common Stock")
2025-07-22$5.44/sh+13,123→ 475,971 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2025-06-11+6,900→ 16,300 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (right to buy)
2025-06-11+10,350→ 10,350 total
Purchase
TScan Therapeutics, Inc.$TCRX
Common Stock
2025-05-20$1.20/sh+1,200,000→ 7,946,141 total
Purchase
TScan Therapeutics, Inc.$TCRX
Common stock, $0.0001 par value per share ("Common Stock")
2025-05-19$1.20/sh+1,388,794→ 6,746,141 total
Purchase
Passage BIO, Inc.$PASG
Common stock, $0.0001 par value per share
2024-12-27$0.65/sh+373,645→ 9,256,953 total
Purchase
TScan Therapeutics, Inc.$TCRX
Pre-funded Warrant (right to buy)
2024-12-26$4.00/sh+7,500,000→ 7,500,000 total
Purchase
TScan Therapeutics, Inc.$TCRX
Common Stock
2024-12-13$2.90/sh+100,000→ 5,357,347 total
Purchase
TScan Therapeutics, Inc.$TCRX
Common stock, $0.0001 par value per share ("Common Stock")
2024-12-12$3.01/sh+31,800→ 5,257,347 total
Purchase
Passage BIO, Inc.$PASG
Common Stock
2024-11-27$0.67/sh+29,300→ 8,883,308 total
Purchase
Passage BIO, Inc.$PASG
Common Stock
2024-11-26$0.71/sh+167,055→ 8,854,008 total
Purchase
Passage BIO, Inc.$PASG
Common stock, $0.0001 par value per share ("Common Stock")
2024-11-25$0.56/sh+259,998→ 8,686,953 total
Purchase
TScan Therapeutics, Inc.$TCRX
Common stock, $0.0001 par value per share
2024-11-15$4.34/sh+947→ 5,225,547 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (right to buy)
2024-06-07+12,500→ 12,500 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2024-06-07+3,400→ 9,400 total
Purchase
TScan Therapeutics, Inc.$TCRX
Pre-funded Warrant (right to buy)
2024-04-19$7.13/sh+5,000,000→ 5,000,000 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (right to buy)
2023-06-16+17,500→ 17,500 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Common Stock
2023-06-16+6,000→ 6,000 total
Sale
TScan Therapeutics, Inc.$TCRX
Common Stock
2023-05-31$2.52/sh−15,000→ 5,225,000 total
Sale
TScan Therapeutics, Inc.$TCRX
Common stock, $0.0001 par value per share Common Stock
2023-05-31$2.51/sh−10,000→ 5,240,000 total
Sale
TScan Therapeutics, Inc.$TCRX
Common Stock
2023-05-31$2.51/sh−400→ 5,224,600 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (right to buy)
2022-06-17+17,500→ 17,500 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (right to buy)
2021-06-22+17,500→ 17,500 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (right to buy)
2020-06-19+12,500→ 12,500 total
Award
Crinetics Pharmaceuticals, Inc.$CRNX
Stock Option (right to buy)
2019-06-21+12,500→ 12,500 total

Companies

Recent Filings

Address

C/O CRINETICS PHARMACEUTICALS, INC. 6055 LUSK BOULEVARD

SAN DIEGO, CA, 92121

View on SEC.gov